Theratechnologies Inc
F:TQ8
Theratechnologies Inc
F:TQ8
Price:
1.92
EUR
27.15%
Market Closed
Market Cap:
€185.9m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
T
|
Theratechnologies Inc
F:TQ8
|
CA |
|
Lithium Americas Corp
F:WUC
|
CA |
|
A
|
Advanced Micro Devices Inc
SWB:AMD
|
US |
|
T
|
Tessenderlo Group NV
F:TEZ
|
BE |
|
P
|
Pexip Holding ASA
XMUN:4W9
|
NO |
|
APA Group
ASX:APA
|
AU |
|
Air Products and Chemicals Inc
XETRA:AP3
|
US |
|
Flughafen Zuerich AG
F:UZAA
|
CH |
|
C
|
CompuGroup Medical SE & Co KgaA
XBER:COP
|
DE |
|
T
|
Trade Desk Inc
F:TT8
|
US |
|
H
|
Hoya Corp
OTC:HOCPY
|
JP |
|
Next Biometrics Group ASA
F:NT7
|
NO |
|
A
|
Accenture PLC
XBER:CSA
|
IE |
|
Gladstone Land Corp
F:3L4
|
US |
|
S
|
SPAR Group Ltd
XBER:S8A
|
ZA |
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is TQ8's stock price target?
Not Available
TQ8 does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Theratechnologies Inc?
Projected CAGR
6%
6%
Over the last 13 years, the compound annual growth rate for Revenue has been 14%. The projected CAGR for the next 3 years is 6%.
What is the Operating Income forecast for Theratechnologies Inc?
Projected CAGR
37%
37%
The compound annual growth rate for Operating Income over the next 3 years is 37%.
